SCHEMBL19989683

SCHEMBL19989683

COC(=O)C(C)(CCN1CC=C(c2ccc(-c3ccc(CN4CCOCC4)cc3)cc2)CC1)S(C)(=O)=O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
HRH3 Q9Y5N1 2/20 0.41
KMT2A Q03164 1/20 0.40
AOC3 Q16853 1/20 0.39
POLB P06746 1/20 0.39
ADAMTS4 O75173 1/20 0.39
MAPK1 P28482 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TSHR P16473 2/20 0.38
USP2 O75604 1/20 0.38
MAPT P10636 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PPARG P37231 2/20 0.38
PPARA Q07869 2/20 0.38
PDE4D Q08499 1/20 0.38
HIF1A Q16665 1/20 0.38
EPAS1 Q99814 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19989633 0.89 SLC6A2 (0.45)
SCHEMBL19989643 0.84 KDM4E (0.40) KDM4EGAAPPARGPPARA
SCHEMBL19989698 0.83 SIGMAR1 (0.45) KDM4EPPARGPPARA
SCHEMBL19989646 0.83 PPARG (0.41) KDM4EMAPTPPARGPPARA
SCHEMBL19989638 0.82 PPARG (0.39) KDM4EPPARGPPARA
SCHEMBL19998283 0.82 DRD2 (0.39) KDM4EGAAPPARGPPARA
SCHEMBL19989692 0.78 DRD3 (0.40) KDM4EPPARGPPARA
SCHEMBL19989613 0.78 DRD2 (0.40) KDM4EMAPTPPARGPPARA
SCHEMBL19989583 0.77 MAPK1 (0.40) KDM4EKMT2AMAPK1PPARGPPARA
SCHEMBL20025448 0.76 HRH3 (0.43) HRH3AOC3POLBMAPK1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3519387-B1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG A ST CO LTD (KR) 2021-08-11 EP disclosed
EP-3519387-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Dong-A ST Co., Ltd. (KR) 2019-08-07 EP disclosed
US-10160724-B2 Tetrahydropyridine derivatives and their use as antibacterial agents DONG-A ST CO., LTD. (KR) 2018-12-25 US disclosed
WO-2018062924-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-04-05 WO disclosed
US-20180086709-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086709-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS GALE, UGDH, PGLS KDM4E 972/4885GAA 224/4885HRH3 1200/4885
US-10160724-B2 Tetrahydropyridine derivatives and their use as antibacterial agents GALE, UGDH, PGLS KDM4E 972/4885GAA 224/4885HRH3 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.